1214101_-_Sole_Source_Notice_-_Elmer_Service.doc

FDA-Sole Source-1214101 Service Maintenance Plan for Perkin Elmer Lamda 25 Spectrophotometers and S10 Autosamplers

The Food and Drug Administration intends to make a sole source award for a Gold Coverage Service Plan for the Maintenance of 4 (four) Perkin Elmer Lamda 25 Spectrophotometers and 2 (two) S10 Autosamplers. The award will be made to:

PerkinElmer Health Sciences, Inc 710 Bridgeport Avenue Shelton, CT 06484-4794 In accordance with FAR 6.302-1, FAR 13.106(b) and FAR 5.203, Only one responsible source and no other supplies or services will satisfy agency requirements.

FDA requires a service plan for the maintenance of 4 (four) Perkin Elmer Lamda 25 Spectrophotometers and 2 (two) S10 Autosamplers, that will include unlimited telephone support for hardware and software, travel to the site of the equipment, Perkin Elmer certified parts, consumables used during repairs, annual preventative maintenance visits and consumables used during the preventative maintenance visits, and a service guarantee stating that if a Perkin Elmer instrument covered by the service agreement cannot be repaired, it will be replaced. Perkin Elmer Health Sciences, Inc is the sole source of Perkin Elmer certified technicians and onsite/phone support of the equipment and software. PerkinElmer Health Sciences, Inc is the original manufacturer of the equipment and their service engineers are trained to maintain and repair their equipment. PerkinElmer provides original parts to repair the equipment. They also have the required trained personnel with the knowledge needed to support efficiently their own equipment better than a third-party source. The use of unoriginal parts and service engineers that are not from the original manufacturer may result in unacceptable performance of the equipment. A third-party vendor cannot achieve the requirements of providing original parts and service engineers from the manufacturer.

This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within five (5) days after the publication of this synopsis which shall be considered by the agency. Responses received after 5 days or without the required information may not be considered. For information concerning this acquisition contact:

Nikola Zuber Contract Specialist Nikola.Zuber@fda.hhs.gov

(301) 796 - 9671 A determination by the Government not to compete because of information received is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement.

1 | Page